Nuclear factor kappaB activity determines the sensitivity of kidney epithelial cells to apoptosis: implications for

Francisco J Dieguez-Acuña1, William W Polk, Maureen E Ellis

  • 1Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.

Insights

Inhibition of Nuclear Factor kappa B (NF-kappaB) with mercuric ions or other inhibitors sensitizes kidney cells to apoptosis. This finding reveals a key mechanism in mercury

Area of Science:

  • Molecular Biology
  • Toxicology
  • Cell Biology

Background:

  • Nuclear factor kappa B (NF-kappaB) is a key transcription factor regulating cell survival and apoptosis.
  • Mercuric ion (Hg(2+)) is a potent thiol-binding agent known to interfere with cellular processes.
  • Kidney epithelial cells normally exhibit resistance to apoptosis induced by certain stimuli.

Purpose of the Study:

  • To investigate if inhibition of NF-kappaB activation by Hg(2+) and other inhibitors increases kidney epithelial cell sensitivity to apoptosis.
  • To elucidate the role of NF-kappaB in protecting kidney cells from apoptotic stimuli.
  • To explore the in vivo relevance of NF-kappaB inhibition in kidney toxicity.

Main Methods:

  • Kidney epithelial cells (NRK52E) were treated with Hg(2+), tumor necrosis factor-alpha (TNF), and specific NF-kappaB inhibitors (Bay11-7082, SN50).
  • Apoptosis was assessed using DNA fragmentation (TUNEL) assays.
  • Cells were transfected with a p65 expression vector to assess rescue effects.
  • In vivo studies involved Hg(2+) and bacterial lipopolysaccharide (LPS) administration in rats, followed by kidney cortical cell analysis.

Main Results:

  • Hg(2+) and TNF alone did not significantly induce apoptosis in kidney cells.
  • Pretreatment with Hg(2+) or NF-kappaB inhibitors followed by TNF significantly increased apoptosis (2- to 6-fold).
  • Transfection with a p65 expression vector attenuated the increased sensitivity to apoptosis.
  • In vivo, Hg(2+) pretreatment impaired NF-kappaB activation and increased cytochrome c release in kidney cortical cells.

Conclusions:

  • Inhibition of NF-kappaB activity enhances the sensitivity of kidney cells to apoptotic stimuli.
  • NF-kappaB plays a critical role in protecting kidney cells from toxicant-induced apoptosis.
  • The findings suggest that impaired NF-kappaB activity is a molecular mechanism underlying mercury toxicity in kidney cells.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...